Japan, July 1 -- JANSSEN PHARMACEUTICA NV,PROTAGONIST THERAPEUTICS INC has got intellectual property rights for 'COMPOSITIONS OF PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR.' Other related details are as follows:

Application Number: JP,2023-119735

Category (FI): A61K47/14,A61K38/12,A61P1/04,A61P17/06,A61P19/02,A61P29/00,A61P43/00,111,A61K9/20,A61K9/48,A61K9/32,A61K9/58,A61K47/32,A61K47/38,A61K47/36,A61K47/26,A61K47/10,A61K47/12,A61K47/18,A61K47/04,A61K47/34,C07K7/08,C12N15/11@Z

Stage: Grant (IP right granted following substantive examination.)

Filing Date: July 24, 2023

Publication Date: Oct. 11, 2023

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....